MedImmune discloses Ethyol issues

In its 10-K filed late Tuesday, MEDI said the FDA may withdraw approval of an sNDA for the company's Ethyol thiophosphate cytoprotective agent

Read the full 237 word article

How to gain access

Continue reading with a
two-week free trial.